Online citations, reference lists, and bibliographies.

Multifactorial Regulation Of E-Cadherin Expression: An Integrative Study

W. Reinhold, M. Reimers, Philip Lorenzi, J. Ho, U. Shankavaram, Micah S Ziegler, K. Bussey, S. Nishizuka, O. Ikediobi, Y. Pommier, J. Weinstein
Published 2010 · Medicine, Biology
Cite This
Download PDF
Analyze on Scholarcy
Share
E-cadherin (E-cad) is an adhesion molecule associated with tumor invasion and metastasis. Its down-regulation is associated with poor prognosis for many epithelial tumor types. We have profiled E-cad in the NCI-60 cancer cell lines at the DNA, RNA, and protein levels using six different microarray platforms plus bisulfite sequencing. Here we consider the effects on E-cad expression of eight potential regulatory factors: E-cad promoter DNA methylation, the transcript levels of six transcriptional repressors (SNAI1, SNAI2, TCF3, TCF8, TWIST1, and ZFHX1B), and E-cad DNA copy number. Combined bioinformatic and pharmacological analyses indicate the following ranking of influence on E-cad expression: (1) E-cad promoter methylation appears predominant, is strongly correlated with E-cad expression, and shows a 20% to 30% threshold above which E-cad expression is silenced; (2) TCF8 expression levels correlate with (−0.62) and predict (P < 0.00001) E-cad expression; (3) SNAI2 and ZFHX1B expression levels correlate positively with each other (+0.83) and also correlate with (−0.32 and −0.30, respectively) and predict (P = 0.03 and 0.01, respectively) E-cad expression; (4) TWIST1 correlates with (−0.34) but does not predict E-cad expression; and (5) SNAI1 expression, TCF3 expression, and E-cad DNA copy number do not correlate with or predict E-cad expression. Predictions of E-cad regulation based on the above factors were tested and verified by demethylation studies using 5-aza-2′-deoxycytidine treatment; siRNA knock-down of TCF8, SNAI2, or ZFHX1B expression; and combined treatment with 5-aza-2′-deoxycytidine and TCF8 siRNA. Finally, levels of cellular E-cad expression are associated with levels of cell-cell adhesion and response to drug treatment. Mol Cancer Ther; 9(1); 1–16
This paper references
Mutation analysis of twentyMol Cancer Ther; 9(1) January 2010 four known cancer genes in the NCI-60 cell line set
ON Ikediobi (2006)
10.1002/mc.10064
CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Leopoldo Alves Ribeiro-Filho (2002)
10.1046/j.1464-410x.2000.00916.x
Molecular markers for predicting prostate cancer stage and survival.
William D. Dunsmuir (2000)
10.1038/73432
Systematic variation in gene expression patterns in human cancer cell lines
D. T. Ross (2000)
The SLUG zinc-finger protein represses E-cadherin in breast cancer.
K. M. Hajra (2002)
10.1016/j.cell.2004.06.006
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
J. Yang (2004)
10.1038/35000034
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E. Batlle (2000)
10.1093/ajcp/105.4.394
Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.
S. Siitonen (1996)
10.1158/1535-7163.MCT-06-0447
Asparagine synthetase as a causal, predictive biomarker for l-asparaginase activity in ovarian cancer cells
Philip L. Lorenzi (2006)
10.1016/S0955-0674(96)80110-4
Cadherins and catenins in development.
O. Huber (1996)
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
S. Nass (2000)
Downloaded from four known cancer genes in the NCI60 cell line set
ON Ikediobi (2006)
10.1074/jbc.M100827200
A New Role for E12/E47 in the Repression ofE-cadherin Expression and Epithelial-Mesenchymal Transitions*
M. Perez-Moreno (2001)
10.1016/S1097-2765(01)00260-X
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.
Joke Comijn (2001)
10.1158/1535-7163.MCT-08-0921
DNA fingerprinting of the NCI-60 cell line panel
Philip L. Lorenzi (2009)
Mechanisms of inactivation of E-cadherin in breast cancer cell lines.
Shunsuke Hiraguri (1998)
10.1158/1535-7163.MCT-05-0155
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel
K. Bussey (2006)
Karyotypic complexity of the NCI-60 drug-screening panel.
A. Roschke (2003)
10.1093/carcin/bgi152
Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
W. Gallagher (2005)
Mutation analysis of twentyfour known cancer genes in the NCI-60 cell line set
O N Ikediobi (2006)
10.1016/S0022-5347(05)66047-8
Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer.
L. Li (2001)
10.1073/pnas.191368598
Chemosensitivity prediction by transcriptional profiling
J. E. Staunton (2001)
10.1158/1535-7163.MCT-07-0009
MicroRNA expression profiles for the NCI-60 cancer cell panel
Paul E. Blower (2007)
10.1002/j.1460-2075.1995.tb00301.x
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
G. Berx (1995)
10.1126/science.7824937
Solution structure of the epithelial cadherin domain responsible for selective cell adhesion
M. Overduin (1995)
10.1038/35013106
CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus
A. T. Hark (2000)
10.1111/j.1464-410X.1997.tb00799.x
The cadherin cell-cell adhesion pathway in prostate cancer progression.
R. Paul (1997)
Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression.
M. Hsu (2000)
ther evidence to support the melanocytic origin of MDAMB435
G Ellison (2002)
Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance
Y Huang (2004)
10.1242/jcs.00224
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors
Victoria Bolós (2003)
10.1016/S1471-4892(02)00185-6
'Omic' and hypothesis-driven research in the molecular pharmacology of cancer.
John N. Weinstein (2002)
10.1002/mc.1060
CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
Dana Nojima (2001)
10.1158/1535-7163.MCT-06-0650
Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study
U. Shankavaram (2007)
10.1038/sj.onc.1202764
Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors
D. Mancini (1999)
10.1158/1535-7163.MCT-06-0609
Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells
William C. Reinhold (2007)
10.1158/1535-7163.MCT-06-0433
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
O. Ikediobi (2006)
10.1016/S0090-4295(02)02110-6
Multipoint methylation and expression analysis of tumor suppressor genes in human renal cancer cells.
Takahiro Kawakami (2003)
10.1073/pnas.1734137100
WNT7a induces E-cadherin in lung cancer cells
T. Ohira (2003)
10.3892/ijo.25.5.1415
Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines.
A. Tsutsumida (2004)
10.1101/gad.1640608
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
S. Park (2008)
10.1016/S0968-0004(98)01343-7
The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.
G. Christofori (1999)
10.1093/hmg/8.4.607
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
F. M. Richards (1999)
10.1073/pnas.2331323100
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays
S. Nishizuka (2003)
10.1136/mp.55.5.294
Further evidence to support the melanocytic origin of MDA-MB-435
Gillian Ellison (2002)
10.1038/ncb1722
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
P. A. Gregory (2008)
10.1038/73439
A gene expression database for the molecular pharmacology of cancer
U. Scherf (2000)
10.1016/j.yexcr.2004.03.012
Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
G. Li (2004)
10.1158/1535-7163.MCT-06-0640
Spotlight on molecular profiling: “Integromic” analysis of the NCI-60 cancer cell lines
J. Weinstein (2006)
10.1124/mol.104.005009
Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug Resistances⃞
Jean-Philippe Annereau (2004)
10.1093/hmg/ddg028
Methylation-sensitive binding of transcription factor YY1 to an insulator sequence within the paternally expressed imprinted gene, Peg3.
J. Kim (2003)
10.1073/pnas.92.16.7416
Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.
K. Yoshiura (1995)
Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.
T. Matsumura (2001)
Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.
S. Stinson (1992)



This paper is referenced by
10.5487/TR.2014.30.4.261
Transformation of Mouse Liver Cells by Methylcholanthrene Leads to Phenotypic Changes Associated with Epithelial-mesenchymal Transition
Jiyun Oh (2014)
10.4103/jomfp.JOMFP_97_19
Extracellular matrix in invasion and metastasis of oral squamous cell carcinoma
K Vinod Kumar (2019)
10.1007/s10549-015-3485-1
Role of epithelial–mesenchymal transition markers in triple-negative breast cancer
Sai Yin Cheung (2015)
10.18632/oncotarget.8888
AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer
X. Liu (2016)
Role of ZEB1 in Tumor Progression: Regulation of Cell Invasion and Senescence
Barrios Barri (2017)
10.1016/j.bbrc.2013.04.060
A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition.
Young-Suk Jung (2013)
10.1152/ajpcell.00148.2010
PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells.
R. Espejo (2010)
10.1186/1471-2164-12-439
Tissue-specific gene expression templates for accurate molecular characterization of the normal physiological states of multiple human tissues with implication in development and cancer studies
Pei-Ing Hwang (2011)
10.1186/s12885-016-2274-5
Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity
Roman Mezencev (2016)
Nanotoxicology on the right track : focus on metal and metal oxide nanoparticles
Anda R. Gliga (2016)
10.1515/hsz-2019-0350
Circular RNA hsa_circ_0001178 facilitates the invasion and metastasis of colorectal cancer through upregulating ZEB1 via sponging multiple miRNAs
Chunfeng Ren (2019)
10.1007/s10637-013-0017-x
OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model
Ilya Tsimafeyeu (2013)
10.1016/j.freeradbiomed.2012.04.031
Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling.
Zhonghua Liu (2012)
Review Article Expanding roles of ZEB factors in tumorigenesis and tumor progression
Ester Sánchez-Tilló (2012)
Avaliação do perfil de metilação e expressão do gene CDH1 em Cebus apella como modelo experimental para câncer gástrico
Symara Rodrigues Antunes (2012)
10.1007/978-3-642-31040-9_6
Cancer Data Integration and Querying with GeneTegra
E. Patrick Shironoshita (2012)
Use of miRNA inhibitors to investigate probiotic regulation of E-cadherin expression
Ashtin Jeney (2019)
10.1158/0008-5472.CAN-11-3059
Targeting quiescent tumor cells via oxygen and IGF-I supplementation.
Alastair Hugh Kyle (2012)
10.1002/ijc.31638
miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
Shih-Yuan Peng (2018)
10.1158/0008-5472.CAN-12-1370
CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.
William C. Reinhold (2012)
10.1016/j.fertnstert.2014.07.005
Genetic variation of the E-cadherin gene is associated with primary infertility in patients with ovarian endometriosis.
Shan Kang (2014)
10.4161/cbt.11.5.14673
Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis
Yoko Matsuda (2011)
10.1039/c0fo00108b
Suppression of breast xenograft growth and progression in nude mice: implications for the use of orally administered sphingolipids as chemopreventive agents against breast cancer.
Kirk W. Simon (2010)
10.1016/j.lungcan.2011.01.019
Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.
Ajaya Kumar Reka (2011)
10.11606/T.5.2014.tde-04082014-102817
Estudo dos genes e microRNAs relacionados à transição epitélio-mesenquimal no adenocarcinoma de próstata
Betina Stifelman Katz (2014)
10.3390/cancers2031617
ZEB1 in Pancreatic Cancer
U. Wellner (2010)
10.1016/j.prp.2014.06.009
Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis.
Anji Anura (2014)
10.1038/nrc.2018.15
Cell motility in cancer invasion and metastasis: insights from simple model organisms
C. Stuelten (2018)
10.3892/ol.2019.10140
Effect of asiatic acid on epithelial-mesenchymal transition of human alveolar epithelium A549 cells induced by TGF-β1
Qingrong Cui (2019)
10.3892/or.2013.2449
Specific reversal of tumor-suppressor gene promoter hypermethylation with bovine oocyte extract.
Zhenfei Wang (2013)
10.1016/j.placenta.2010.09.011
Evaluating DNA methylation and gene expression variability in the human term placenta.
Luana Avila (2010)
10.3390/ijms21134734
Effects of DSPP and MMP20 Silencing on Adhesion, Metastasis, Angiogenesis, and Epithelial-Mesenchymal Transition Proteins in Oral Squamous Cell Carcinoma Cells
Jaya Aseervatham (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar